Literature DB >> 10729732

Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors.

R H Holloway1, J Dent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729732     DOI: 10.1159/000016928

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


× No keyword cloud information.
  4 in total

1.  Anti-relaxation therapy in GORD.

Authors:  J Tack; D Sifrim
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Beyond acid suppression: new pharmacologic approaches for treatment of GERD.

Authors:  Paul Kuo; Richard H Holloway
Journal:  Curr Gastroenterol Rep       Date:  2010-06

3.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 4.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.